Table 1.
Advantages |
Patient and carer satisfaction because of ease of use and tolerability |
Limiting hepatic first-pass metabolism, hence lower dose of medication can obtain desired |
lasma level compared with oral formulations |
Reduced frequency of dosing |
Constant drug serum level versus episodic peaks |
Reduced side effects secondary to gastrointestinal intolerance and fluctuations of drug levels |
Avoidance of unpleasant and inconvenient parental administration |
Easier to titrate to achieve optimal therapeutic doses |
Potentially reduces the risk of drug overdose |
Removal of the patch stops drug delivery |
Disadvantages |
Slow time towards peak plasma levels |
Unsuitable model for emergency treatments that requires rapid release of desired drug and rapid serum levels |
Limited choice of medication that may be formulated in transdermal format |
Variations in bioavailability (see Table 2) |
Skin sensitivity and application allergic reactions |
Steady state of drug is maintained only as long as the patch is applied |
Good adherence to skin is necessary for patches to be effective. Presence of oil, hair or sweat on the patch application site can be hindrances to adherence and can cause variations in absorption. |
TDS involves learning the appropriate application technique |
Potential medication error such as using multiple patches |
TDS can be costlier than oral formulations |
Complex issues such as: monitoring cumulative effects of long-term use emerging research evidence and lack of randomized controlled trials and economic evaluation ethical and legal dilemmas in situations where capacity and consent to treatment are in question |